Anticoagulation for the initial treatment of venous thromboembolism in people with cancer-Reference-Cited by-同舟云学术

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer

Published:2018-01-24 Issue:2 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hakoum Maram B¹,Kahale Lara A²,Tsolakian Ibrahim G²,Matar Charbel F³,Yosuico Victor ED⁴,Terrenato Irene⁵,Sperati Francesca⁵,Barba Maddalena⁶,Schünemann Holger⁷,Akl Elie A³

Affiliation:

1. American University of Beirut; Family Medicine; Beirut Lebanon 1107 2020

2. American University of Beirut; Faculty of Medicine; Beirut Lebanon

3. American University of Beirut Medical Center; Department of Internal Medicine; Riad El Solh Beirut Lebanon 1107 2020

4. Buffalo Medical Group; 85 High Street Buffalo New York USA 14203-1149

5. Regina Elena National Cancer Institute; Biostatistics-Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144

6. IRCCS Regina Elena National Cancer Institute; Division of Medical Oncology 2 - Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144

7. McMaster University; Departments of Health Research Methods, Evidence, and Impact and of Medicine; 1280 Main Street West Hamilton ON Canada L8N 4K1

Publisher

Wiley

Subject

Pharmacology (medical)

Reference182 articles.

1. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis;Breddin;New England Journal of Medicine,2001

2. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism;Buller;New England Journal of Medicine,1997

3. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicenter study;Duroux;Thrombosis and Haemostasis,1991

4. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis;Hull;New England Journal of Medicine,1992

5. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group;Koopman;New England Journal of Medicine,1996

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023);Clinical and Translational Oncology;2024-08-07

2. Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »;La Revue de Médecine Interne;2024-06

3. Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study;Thrombosis Research;2024-05

4. A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer;Thoracic Cancer;2024-01-17

5. Management of cancer-associated thromboembolism in vulnerable population;Archives of Cardiovascular Diseases;2024-01